Prescriptions made by Boyd Edwin Sprenkle

Data for 2018

3,042

Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 174 providers in this state and specialty

$887.1K

Total Retail Price of All Prescriptions

Rank: 34 out of 174 providers in this state and specialty

338

Patients Receiving at Least One Drug in Part D

Rank: 23 out of 174 providers in this state and specialty

77%

Patients 65 Years and Older

71

Average Age of Patients

Average age of patients for providers in this state and specialty is 71

Drug Categories

O

Opioid

An opioid drug. Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.
A

Antibiotic

Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.
P

Antipsychotic

Used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders.

Prescription Data

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume. Rank in State ranks all providers that have the self-identified specialty of Pulmonary Disease in Maryland and ranks the number of prescriptions that have been made for the specific drug.

Drug Name Rank in State Total Prescriptions Filled with Refills Prescript. to 65+ Patients Receiving this Drug Patients 65+ OAP
1 SYMBICORT
(BUDESONIDE/FORMOTEROL FUMARATE)
50
of 1240
2680 prescriptions
Less than 1% of all prescriptions
1700650 patients
19% of all patients
420 patients
12% of all patients
2 VENTOLIN HFA
(ALBUTEROL SULFATE)
30
of 1260
3060 prescriptions
Less than 1% of all prescriptions
17101060 patients
31% of all patients
700 patients
21% of all patients
3 MONTELUKAST SODIUM150
of 1080
2120 prescriptions
Less than 1% of all prescriptions
1420460 patients
14% of all patients
270 patients
8% of all patients
4 PROAIR HFA
(ALBUTEROL SULFATE)
40
of 1130
2110 prescriptions
Less than 1% of all prescriptions
1640680 patients
20% of all patients
520 patients
15% of all patients
5 ADVAIR DISKUS
(FLUTICASONE PROPION/SALMETEROL)
140
of 1070
1500 prescriptions
Less than 1% of all prescriptions
1170350 patients
10% of all patients
< 11
6 PREDNISONE80
of 1220
2570 prescriptions
Less than 1% of all prescriptions
15301030 patients
30% of all patients
740 patients
22% of all patients
7 BREO ELLIPTA
(FLUTICASONE/VILANTEROL)
240
of 1080
1420 prescriptions
Less than 1% of all prescriptions
1120360 patients
11% of all patients
< 11
8 SPIRIVA
(TIOTROPIUM BROMIDE)
130
of 1050
1080 prescriptions
Less than 1% of all prescriptions
970300 patients
9% of all patients
< 11
9 INCRUSE ELLIPTA
(UMECLIDINIUM BROMIDE)
100
of 960
1420 prescriptions
Less than 1% of all prescriptions
1130320 patients
9% of all patients
< 11
10 SPIRIVA RESPIMAT
(TIOTROPIUM BROMIDE)
90
of 980
1000 prescriptions
Less than 1% of all prescriptions
750260 patients
8% of all patients
< 11
11 FLUTICASONE PROPIONATE150
of 890
820 prescriptions
Less than 1% of all prescriptions
340 patients
10% of all patients
< 11
12 DALIRESP
(ROFLUMILAST)
20
of 470
830 prescriptions
Less than 1% of all prescriptions
680160 patients
5% of all patients
< 11
13 TRELEGY ELLIPTA
(FLUTICASONE/UMECLIDIN/VILANTER)
100
of 530
590 prescriptions
Less than 1% of all prescriptions
460210 patients
6% of all patients
< 11
14 ANORO ELLIPTA
(UMECLIDINIUM BRM/VILANTEROL TR)
320
of 1050
780 prescriptions
Less than 1% of all prescriptions
510160 patients
5% of all patients
< 11
15 STIOLTO RESPIMAT
(TIOTROPIUM BR/OLODATEROL HCL)
20
of 630
660 prescriptions
Less than 1% of all prescriptions
160130 patients
4% of all patients
< 11
16 PANTOPRAZOLE SODIUM50
of 370
460 prescriptions
Less than 1% of all prescriptions
200110 patients
3% of all patients
< 11
17 AZELASTINE HCL140
of 330
330 prescriptions
Less than 1% of all prescriptions
200140 patients
4% of all patients
< 11
18 ADVAIR HFA
(FLUTICASONE PROPION/SALMETEROL)
60
of 380
700 prescriptions
Less than 1% of all prescriptions
540150 patients
4% of all patients
< 11
19 DULERA
(MOMETASONE/FORMOTEROL)
10
of 220
350 prescriptions
Less than 1% of all prescriptions
130 patients
4% of all patients
< 11
20 FLOVENT HFA
(FLUTICASONE PROPIONATE)
60
of 430
400 prescriptions
Less than 1% of all prescriptions
270< 11< 11
21 ARNUITY ELLIPTA
(FLUTICASONE FUROATE)
70
of 510
480 prescriptions
Less than 1% of all prescriptions
< 11< 11
22 IPRATROPIUM BROMIDE70
of 220
330 prescriptions
Less than 1% of all prescriptions
190 patients
6% of all patients
< 11
23 AZITHROMYCIN440
of 960
280 prescriptions
Less than 1% of all prescriptions
140 patients
4% of all patients
< 11A
24 BEVESPI AEROSPHERE
(GLYCOPYRROLATE/FORMOTEROL FUM)
80
of 200
160 prescriptions
Less than 1% of all prescriptions
< 11< 11
25 THEOPHYLLINE ANHYDROUS70
of 180
250 prescriptions
Less than 1% of all prescriptions
< 11< 11
26 COMBIVENT RESPIMAT
(IPRATROPIUM/ALBUTEROL SULFATE)
160
of 620
280 prescriptions
Less than 1% of all prescriptions
< 11< 11
27 TUDORZA PRESSAIR
(ACLIDINIUM BROMIDE)
20
of 80
280 prescriptions
Less than 1% of all prescriptions
< 11< 11
28 WARFARIN SODIUM50
of 50
170 prescriptions
Less than 1% of all prescriptions
170< 11< 11
29 PULMICORT FLEXHALER
(BUDESONIDE)
80
of 190
160 prescriptions
Less than 1% of all prescriptions
160< 11< 11
30 AMOXICILLIN-CLAVULANATE POTASS
(AMOXICILLIN/POTASSIUM CLAV)
20
of 310
580 prescriptions
Less than 1% of all prescriptions
460500 patients
15% of all patients
390 patients
12% of all patients
A
31 LEVALBUTEROL TARTRATE HFA
(LEVALBUTEROL TARTRATE)
40
of 60
120 prescriptions
Less than 1% of all prescriptions
< 11< 11
32 DOXYCYCLINE HYCLATE20
of 230
430 prescriptions
Less than 1% of all prescriptions
290350 patients
10% of all patients
230 patients
7% of all patients
A
33 PROVENTIL HFA
(ALBUTEROL SULFATE)
30
of 40
150 prescriptions
Less than 1% of all prescriptions
< 11< 11
34 LEVOFLOXACIN110
of 420
320 prescriptions
Less than 1% of all prescriptions
170210 patients
6% of all patients
< 11A
35 CLARITHROMYCIN30
of 50
170 prescriptions
Less than 1% of all prescriptions
110 patients
3% of all patients
< 11A